Moffitt Cancer Center Scientific Symposium
Moffitt Cancer Center shared on X:
“At Moffitt Scientific Symposium, Ashley Whitmer joined Patrick Hwu to discuss the patient and provider perceptions about Cervical Cancer therapeutic vaccines.
PhD Student, Hannah Walker-Mimms, joined Patrick Hwu during the Moffitt Scientific Symposium to discuss the treatment of headband neck cancer with a combination of a CHK1/2 dual inhibitor (prexasertib) and nucleoside analog (gemcitabine).
During Moffitt Scientific Symposium, Mariam Khaled joined Patrick Hwu to discuss branched-chain keto acid-lowering therapy and managing neurological decline in leptomeningeal disease.
Anastasia Murphy and Lee Green, joined Patrick Hwu to discuss the narrative review focused on AI and cancer disparities during Moffitt Scientific Symposium.
During Moffitt Scientific Symposium, Patrick Hwu joined Samira Naderinezhad to talk about the potential therapeutic benefits of HNB in CAR-T cells by enhancing metabolic fitness and increasing the number of mitochondria.
During Moffitt Scientific Symposium, Joshua Wright, was joined by Patrick Hwu to discuss breast biopsy bleeding outcomes for patients on antithrombotic.
That’s a wrap on the 14th Annual Moffitt Scientific Symposium! Today, trainees from across the cancer center came together to learn and collaborate, advancing our mission to save lives.”
Source: Moffitt Cancer Center/X
Moffitt Cancer Center, established in 1986, is a leading institution dedicated to cancer research, treatment, and prevention. With a multidisciplinary approach and state-of-the-art facilities, Moffitt’s commitment to innovative research is reflected in its five multidisciplinary research programs, which integrate teams focused on cancer biology and evolution, chemical biology and molecular medicine, immunology, health outcomes and behavior, and cancer epidemiology. Since receiving its NCI designation in 1998 and NCI-Designated Comprehensive Cancer Center status in 2001, Moffitt Cancer Center continues to lead the charge in advancing cancer care, providing hope and healing to patients worldwide.
